renal cell carcinoma

Open Access
Timescale-dependent Phosphoproteomic Remodeling and Motility-associated Adaptation under Chronic Cabozantinib Exposure in Renal Cell Carcinoma
SHAO-KUAN CHEN, YEN-CHIEH WANG, YU-HENG HSIEH, CHI-JUNG HUANG and WEI-CHI KU

Cancer Genomics & Proteomics March 2026, 23 (2) 265-280; DOI: https://doi.org/10.21873/cgp.20576
Open Access
Circulating Serum piRNAs as Diagnostic and Prognostic Tools for Clear Cell Renal Cell Carcinoma
MAREK KASIK, ROBERT ILIEV, PETRA VYCHYTILOVA, SILVIA RYBECKA, LENKA RADOVA, MICHAL STANIK, MICHAL FEDORKO, JAN DOLEZEL, ONDREJ SLABY and JULIA BOHOSOVA

Cancer Genomics & Proteomics November 2025, 22 (6) 888-899; DOI: https://doi.org/10.21873/cgp.20545
Open Access
CYBA as a Potential Biomarker for Renal Cell Carcinoma: Evidence from an Integrated Genetic Analysis
CHI-FEN CHANG, SHU-PIN HUANG, YU-MEI HSUEH, PEI-LING CHEN, CHENG-HSUEH LEE, JIUN-HUNG GENG, CHAO-YUAN HUANG and BO-YING BAO

Cancer Genomics & Proteomics September 2023, 20 (5) 469-475; DOI: https://doi.org/10.21873/cgp.20398
Open Access
Concurrent Reduced Expression of Contiguous PKD1, TSC2 and NTHL1 Leading to Kidney Diseases and Multiple Diverse Renal Cancers
SATORU MEGURO, TOMOYUKI KOGUCHI, YUSUKE HAKOZAKI, AKIFUMI ONAGI, KANAKO MATSUOKA, SEIJI HOSHI, JUNYA HATA, YUICHI SATO, HIDENORI AKAIHATA, MASAO KATAOKA, SOICHIRO OGAWA and YOSHIYUKI KOJIMA

Cancer Genomics & Proteomics January 2023, 20 (1) 40-50; DOI: https://doi.org/10.21873/cgp.20363
You have access
G-Protein-coupled Estrogen Receptor 1 Agonist G-1 Perturbs Sunitinib Resistance-related Phosphoproteomic Signatures in Renal Cell Carcinoma
SHAO-KUAN CHEN, YEN-CHIEH WANG, TAI-YUAN LIN, HSIN-JOU WU, CHI-JUNG HUANG and WEI-CHI KU

Cancer Genomics & Proteomics May 2021, 18 (3) 207-220; DOI: https://doi.org/10.21873/cgp.20253
You have access
Profiling of Serum Extracellular Vesicles Reveals miRNA-4525 as a Potential Biomarker for Advanced Renal Cell Carcinoma
YUKA MURAMATSU-MAEKAWA, KYOJIRO KAWAKAMI, YASUNORI FUJITA, MANABU TAKAI, DAIKI KATO, KEITA NAKANE, TAKU KATO, TOMOHIRO TSUCHIYA, TAKUYA KOIE, YURI MIURA, MASAFUMI ITO and KOSUKE MIZUTANI

Cancer Genomics & Proteomics May 2021, 18 (3) 253-259; DOI: https://doi.org/10.21873/cgp.20256
Open Access
Genetic Analysis Identifies the Role of HLF in Renal Cell Carcinoma
CHAO-YUAN HUANG, SHU-PIN HUANG, YU-MEI HSUEH, LIH-CHYANG CHEN, TE-LING LU and BO-YING BAO

Cancer Genomics & Proteomics November 2020, 17 (6) 827-833; DOI: https://doi.org/10.21873/cgp.20236
Open Access
MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients
JULIA KOVACOVA, JAROSLAV JURACEK, ALEXANDR POPRACH, JINDRICH KOPECKY, ONDREJ FIALA, MAREK SVOBODA, PAVEL FABIAN, LENKA RADOVA, PETR BRABEC, TOMAS BUCHLER and ONDREJ SLABY

Cancer Genomics & Proteomics September 2019, 16 (5) 353-359; DOI: https://doi.org/10.21873/cgp.20140
Open Access
Dual Roles of 17-β Estradiol in Estrogen Receptor-dependent Growth Inhibition in Renal Cell Carcinoma
KUO-CHIANG CHEN, CHIH-MING LIN, CHI-JUNG HUANG, SHAO-KUAN CHEN, SHENG-TANG WU, HAN-SUN CHIANG and WEI-CHI KU

Cancer Genomics & Proteomics May 2016, 13 (3) 219-230;

Main menu

User menu

Search

renal cell carcinoma